All Stories

  1. Editorial: Nanomaterials for the diagnosis and therapy of viral infections
  2. Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients
  3. Antibody response to BTN162b2 mRNA vaccination in naïve versus SARS-CoV-2 infected subjects with and without waning immunity
  4. Control of the Autophagy Pathway in Osteoarthritis: Key Regulators, Therapeutic Targets and Therapeutic Strategies
  5. SARS-CoV-2 Vaccination Elicits Unconventional IgM Specific Responses in Naïve and Previously COVID19-Infected Individuals
  6. Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
  7. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
  8. The Emerging Role of the RBM20 and PTBP1 Ribonucleoproteins in Heart Development and Cardiovascular Diseases
  9. Benzodiazepine Use and HIV-Associated Neurocognitive Impairment: Which Comes First?
  10. A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells
  11. Molecular and Lifestyle Factors Modulating Obesity Disease
  12. NF-κB and MicroRNA Deregulation Mediated by HTLV-1 Tax and HBZ
  13. CRISPR/Cas system: An emerging technology in stem cell research
  14. Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma
  15. TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins
  16. Runx2 stimulates neoangiogenesis through the Runt domain in melanoma
  17. Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player
  18. Inflammation in Cancer: Part of the Problem or Part of the Solution?
  19. RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3
  20. HIV-1-Associated Neurocognitive Disorders: Is HLA-C Binding Stability to β2-Microglobulin a Missing Piece of the Pathogenetic Puzzle?
  21. Correction for Parolini et al., “Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity”
  22. Erratum: Corrigendum: HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity
  23. HTLV Deregulation of the NF-κB Pathway: An Update on Tax and Antisense Proteins Role
  24. HLA-C stabiliy modulates HIV-1 infectivity
  25. IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia
  26. HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity
  27. Molecular characterization of HIV-1 Nef and ACOT8 interaction: insights from in silico structural predictions and in vitro functional assays
  28. Comment on "Influence of HLA-C Expression Level on HIV Control"
  29. Gelsolin activity controls efficient early HIV-1 infection
  30. HLA-C and HIV-1: friends or foes?
  31. C3 HIV-1 Env and HLA-C
  32. 157a HLA-C Associates with Env and Increases HIV-1 Infectivity
  33. HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes
  34. Unsung Hero Robert C. Gallo
  35. Analysis of colorectal cancers for human cytomegalovirus presence
  36. HLA-C increases HIV-1 infectivity and is associated with gp120
  37. Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes
  38. Coinfection With HIV-1 and Human T-Cell Lymphotropic Virus Type II in Intravenous Drug Users Is Associated With Delayed Progression to AIDS
  39. New vaccine strategies for chronic viral infections
  40. Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types.
  41. Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells
  42. Short Communication: Geographic and Demographic Differences in the Frequency of Human Cytomegalovirus gB Genotypes 1–4 in Immunocompromised Patients
  43. Quantitation Of Human Cytomegalovirus DNA From Peripheral Blood Cells Of Human Immunodeficiency Virus-Infected Patients Could Predict Cytomegalovirus Retinitis
  44. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group.
  45. Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction
  46. Identification of a human cytomegalovirus mutant in the pp150 matrix phosphoprotein gene with a growth-defective phenotype
  47. Human Cytomegalovirus Infection of the Major Leukocyte Subpopulations and Evidence for Initial Viral Replication in Polymorphonuclear Leukocytes from Viremic Patients
  48. Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leuckocytes from AIDS patients with human cytomegalovirus viraemia
  49. Monitoring of Human Cytomegalovirus Infections and Ganciclovir Treatment in Heart Transplant Recipients by Determination of Viremia, Antigenemia, and DNAemia